Skip to main navigation Skip to search Skip to main content

Extension Study for Setmelanotide (RM493-022)

Project: Research

Project Details

StatusFinished
Effective start/end date02/10/2102/16/26

Funding

  • Rhythm Pharmaceuticals Incorporated: $126,872.29